Senator inquires about FDA approval of ReGen knee implant

03/10/2009 | Wall Street Journal (free content), The

Sen. Chuck Grassley, R-Iowa, sent letters to ReGen Biologics and the FDA requesting information related to the agency's approval last fall of a knee implant made by ReGen. Grassley's inquiry comes after a report appeared in The Wall Street Journal on Friday about a controversy surrounding the approval.

View Full Article in:

Wall Street Journal (free content), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Counsel I – Clinical Contracts
Gilead Sciences
Foster City, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Vice President, Idaho Regional Director
Boise, ID